Cargando…

Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo

This study was designed to evaluate the synergism of two couples of antihypertensive drugs (amlodipine + telmisartan and amlodipine + candesartan) on blood pressure reduction in vivo by both SynergyFinder 3.0 and probability sum test. Spontaneously hypertensive rats were treated with intragastric ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Tian, Xu, Lu‐Lu, Guo, Peng‐Yue, Shi, Wan‐Ting, Cheng, Yan‐Qiong, Liu, Ai‐Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944853/ https://www.ncbi.nlm.nih.gov/pubmed/36810974 http://dx.doi.org/10.1002/prp2.1064

Ejemplares similares

SynergyFinder 2.0: visual analytics of multi-drug combination synergies
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
por: Ianevski, Aleksandr, et al.
Publicado: (2022)

Correction to ‘SynergyFinder 2.0: visual analytics of multi-drug combination synergies’
Publicado: (2022)

SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets
por: Zheng, Shuyu, et al.
Publicado: (2022)

SynergyFinder: a web application for analyzing drug combination dose–response matrix data
por: Ianevski, Aleksandr, et al.
Publicado: (2017)

SynergyFinder: a web application for analyzing drug combination dose–response matrix data
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

Cost Effectiveness Analysis of Candesartan Therapy in Comparison to Candesartan-Amlodipine Therapy on Hypertensive Outpatients
por: Baroroh, Faridah, et al.
Publicado: (2019)

Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects
por: Kang, Woo Youl, et al.
Publicado: (2018)

Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study
por: Higaki, Jitsuo, et al.
Publicado: (2016)

Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy
por: Neldam, Steen, et al.
Publicado: (2013)

Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension
por: Segura, Julian, et al.
Publicado: (2011)

Intoxication with massive doses of amlodipine and candesartan requiring venoarterial extracorporeal membrane oxygenation
por: Yusuke, Minagawa, et al.
Publicado: (2023)

Antihypertensive treatment with telmisartan in a cat with amlodipine-induced gingival hyperplasia
por: Desmet, Lien, et al.
Publicado: (2017)

S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial
por: Jo, Sang-Ho, et al.
Publicado: (2018)

No pharmacokinetic interactions between candesartan and amlodipine following multiple oral administrations in healthy subjects
por: Kim, Jung-Ryul, et al.
Publicado: (2018)

Effect of a fixed-dose combination of Telmisartan/S-amlodipine on circadian blood pressure compared with Telmisartan monotherapy: TENUVA-BP study
por: Kim, Bong-Joon, et al.
Publicado: (2022)

Efficacy of Combination Therapy with Telmisartan Plus Amlodipine in Patients with Poorly Controlled Hypertension
por: Bekki, Hisatoshi, et al.
Publicado: (2010)

Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
por: Jin, Xuan, et al.
Publicado: (2020)

Corrigendum to ‘Antihypertensive treatment with telmisartan in a cat with amlodipine-induced gingival hyperplasia’
Publicado: (2022)

Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority Trial
por: Dash, Ashish, et al.
Publicado: (2023)

Effects of Telmisartan and Candesartan on the Metabolism of Lipids and Glucose in Kidney Transplant Patients: A Prospective, Randomized Crossover Study
por: Miura, Yoshifumi, et al.
Publicado: (2019)

Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension
por: Billecke, Scott S, et al.
Publicado: (2013)

Difference in the effects of switching from Candesartan to Olmesartan or Telmisartan to Olmesartan in hypertensive patients with type 2 diabetes: the COTO study
por: Daikuhara, Hiroyuki, et al.
Publicado: (2014)

A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide
por: Segura, Julian, et al.
Publicado: (2013)

Dual contrast CMR for evaluation of telmisartan and amlodipine combination therapy in the diabetic murine myocardial injury model
por: Kim, Paul J, et al.
Publicado: (2013)

Strengths finder 2.0
por: Rath, Tom
Publicado: (2007)

Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke
por: Kikuchi, Kiyoshi, et al.
Publicado: (2013)

Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers
por: Oh, Minkyung, et al.
Publicado: (2017)

Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects
por: Moon, Seol Ju, et al.
Publicado: (2019)

QbD Consideration for Developing a Double-Layered Tablet into a Single-Layered Tablet with Telmisartan and Amlodipine
por: Kim, Joo-Eun, et al.
Publicado: (2022)

Proteome TopFIND 3.0 with TopFINDer and PathFINDer: database and analysis tools for the association of protein termini to pre- and post-translational events
por: Fortelny, Nikolaus, et al.
Publicado: (2014)

Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics
por: Grahovac, Jelena, et al.
Publicado: (2019)

Efficacy and Tolerability of Telmisartan Plus Amlodipine in Asian Patients Not Adequately Controlled on Either Monotherapy or on Low-Dose Combination Therapy
por: Zhu, Dingliang, et al.
Publicado: (2014)

Influence of G-protein β-Polypeptide 3 C825T Polymorphism on Antihypertensive Response to Telmisartan and Amlodipine in Chinese Patients
por: Zhang, Zan-Lin, et al.
Publicado: (2016)

Simultaneous determination of telmisartan and amlodipine in human plasma by LC–MS/MS and its application in a human pharmacokinetic study
por: Ravi, Vasu Babu, et al.
Publicado: (2012)

Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study
por: Ihm, Sang-Hyun, et al.
Publicado: (2016)

Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects
por: Lee, Hae Won, et al.
Publicado: (2020)

Jet Finder Library: version 1.0
por: Bosman, M, et al.
Publicado: (1998)

Candesartan in heart failure
por: Ripley, Toni L, et al.
Publicado: (2006)

Efficacy and safety of low‐dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double‐blind, parallel, phase II trial
por: Sung, Ki‐Chul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i7023coui3199fapvddo1j52e2